Our results suggest that tumors showing high expression of CCDC85A (e.g., gastric and pancreatic cancer) may be refractory to ER stress; therefore, treatments such as CDDP, which induce ER stress, are less effective than they are against CCDC85A-negative tumors. The gene discussed is CCDC85A; the disease is pancreatic neoplasm.